{"id":"iron-bisglycinate-oral-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset (nausea, constipation, abdominal discomfort)"},{"rate":null,"effect":"Dark stools"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iron bisglycinate is a chelate complex of iron bound to the amino acid glycine, which enhances intestinal absorption compared to non-chelated iron salts. The glycine ligand protects iron from interactions with dietary inhibitors and reduces gastrointestinal irritation. Once absorbed, iron is incorporated into hemoglobin and myoglobin, and stored as ferritin to treat or prevent iron deficiency anemia.","oneSentence":"Iron bisglycinate provides bioavailable iron in a chelated form that is absorbed in the gastrointestinal tract to replenish iron stores and support hemoglobin synthesis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:17:14.148Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia"},{"name":"Iron supplementation in pregnancy or lactation"}]},"trialDetails":[{"nctId":"NCT04017598","phase":"PHASE4","title":"Potential Harms of Untargeted Iron Supplementation in Cambodia Where Iron Deficiency is Not the Cause of Anemia","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2019-12-10","conditions":"Anemia, Iron Deficiency, Anemia, Intestinal Inflammation","enrollment":480},{"nctId":"NCT03009578","phase":"PHASE3","title":"Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-02-01","conditions":"Anemia","enrollment":100},{"nctId":"NCT03378791","phase":"PHASE3","title":"Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women","status":"COMPLETED","sponsor":"Hatem AbuHashim","startDate":"2015-12-31","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Iron bisglycinate Oral Tablet","genericName":"Iron bisglycinate Oral Tablet","companyName":"Hatem AbuHashim","companyId":"hatem-abuhashim","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iron bisglycinate provides bioavailable iron in a chelated form that is absorbed in the gastrointestinal tract to replenish iron stores and support hemoglobin synthesis. Used for Iron deficiency anemia, Iron supplementation in pregnancy or lactation.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}